● The company's attractive earnings multiples are brought to light by a P/E ratio at 9.16 for the current year.
● The company's share price in relation to its net book value makes it look relatively cheap.
● The company has a low valuation given the cash flows generated by its activity.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
● The overall consensus opinion of analysts has deteriorated sharply over the past four months.
● Over the past twelve months, analysts' opinions have been revised negatively.
● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.